“Differential Cardiometabolic Effects of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Early-Onset Type 2 Diabetes: A Randomized Controlled Trial”, LMJHCR, vol. 4, no. 1, pp. 1–9, Jun. 2026, doi: 10.61919/061x6w21.